HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 1, 1998, Pages 56-61

  Perri, F ^a   Annese, V ^a   Piepoli, A ^a   Napolitano, G ^a   Lombardi, G ^a   Ciavarella, G ^a   Di Giorgio, G ^a   Andriulli, A ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

ANCA; Genetics; HLA; IBD; Ulcerative colitis

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; MARKER; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; GENE LOCUS; GENETIC MARKER; HUMAN; ITALY; ULCERATIVE COLITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; COLITIS, ULCERATIVE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; MALE; NEUTROPHILS; PREVALENCE;

EID: 0031943009     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Yang H, Shohat T, Rotter 31. The genetics of inflammatory bowel disease. In: Inflammatory bowel disease. MacDermott RP, Stenson WF, editors. New York: Elsevier Science Publishing Co, Inc., 1992; 17-51.
2. Satsangi }, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994;35:696-700.
3. Tysk C, Lindberg E, Jamerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988:29:990-6.
4. Tiwari JL, Terasaki PI. HLA and disease associations. New York: Springer-Verlag, 1985;32-48.
5. Sugimura K, Asakura H, Mizuki N, Inoue M, Hibi T, Yagita A, et al. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol 1993;36:112-8.
6. Toyoda H, Wang SJ, Yang H, Redford D, Magalong D, Tyan D, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993:104:741-8.
7. Gardener KR, Crockard AD, Halliday MI, Rowlands BJ. Class H major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease. Gut 1994;35:511-6.
8. Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995:109:1462-7.
9. Reishagen M, Loeliger C, Kuehnl P, Weiss U, Manfras BJ, Adler G, et al. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut 1996:38:538-42.
10. Danzé PM, Colombel JF, Jacquot S, Loste MN, Heresbach D, Ategbo S, et al. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 1996:39:69-72.
11. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990:86:202-10.
12. Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol 1994;95:490-7.
13. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BME, Pena AS, et al. Serum antineutrophil autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993:34:46-50.
14. Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland LR, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992:103:456-61.
15. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibodypositive subgroup. Gastroenterology 1995:108:423-7.
16. Yang H, Rotter JI, Toyoda H, Landers C, Tyan D, McElree C, et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II and subclinical antineutrophil cy-toplasmic antibodies) markers. J Clin Invest 1993;92:1080-4.
17. Yang H, Targan SR, Toyoda H, Tyan D, Landers C, McElree CK, et al. Exploring the mode of inheritance of ANCA+ and ANCAulcerative colitis in the HLA locus. Gastroenterology 1993;104:A804. -
18. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968;21:31-50.
19. Oudkerk Pool M, Roca M, Reumaux D, Bouma G, Pena AS, Colombel JF, et al. The value of pANCA as a serological marker for ulcerative colitis in different European regions. Eur J Gastroent Hepatol 1994;6:399-403.
20. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treat-ment of left-sided ulcerative colitis: results of a pilot study. Mayo ClinProc 1996:71:431-6.
21. Vecchi M, Gionchetti P, Bianchi MB, Belluzzi A, Meucci G, Campieri M, et al. p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal anastomosis. Lancet 1994;344:886-7.
22. Lundin KEA, Ronningen KS, Aono S, Spurkland A, Gaudernack G, Isshiki G. HLA-DQ antigens and DQ amino acid 57 of Japanese patients with insulin-dependent diabetes mellitus: detection of a DRwSDQwS haplotype. Tissues Antigens 1989;34:233-7.
23. Sollid L, Markussen G, Ek J. Evidence for a primary association of coeliac disease to a particular HLA-DQ o/ heterodimer. J Exp Med 1989:169:345-50.